Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of centrally acting agents. Its structure supports the creation of bioactive molecules due to the presence of a primary amine and a constrained ring system, which can enhance metabolic stability and receptor selectivity. Commonly employed in medicinal chemistry for designing drugs targeting neurological disorders, including antidepressants and antipsychotics. Also utilized in the preparation of novel enzyme inhibitors and receptor modulators, where the amine group allows for easy derivatization into amides, sulfonamides, or ureas. Its cyclic ether moiety contributes to improved solubility and pharmacokinetic properties in drug candidates.